Arch Therapeutics, Inc. to Present at the Virtual Investor Fireside Chat Series
June 08, 2020 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., June 08, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel wound care and biosurgical devices, today announced that...
Global Advanced Wound Care Market to Witness 6.3% CAGR During 2020 – 2025, Attaining the Market Size of USD 15.8 billion by 2025: VynZ Research
May 27, 2020 12:19 ET
|
VynZ Research
NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) -- The global advanced wound care market is predicted to grow at 6.3% CAGR during the forecast period with the market size reaching USD 15.8 billion by 2025....
Arch Therapeutics to Provide Corporate Update at the 2020 LD Micro Virtual Investor Conference
March 02, 2020 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., March 02, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Integra LifeSciences Launches AmnioExcel® Plus Placental Allograft Membrane
February 24, 2020 16:15 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of AmnioExcel® Plus...
ViaDerma, Inc. Provides a Corporate Update
January 16, 2020 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Jan. 16, 2020 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide this corporate update: A new 55 ml spray bottle for use in hospitals has been...
Arch Therapeutics to Provide Corporate Update at Biotech Showcase™ 2020 on January 13th, 2020
January 08, 2020 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
RenovaCare Stockholder Update and 2020 Outlook from the CEO
December 05, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Dec. 05, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other...
Dr. Emanual Maverakis, Recipient of Presidential Award for Scientists and Engineers, Joins RenovaCare
November 26, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Nov. 26, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
Advanced Wound Care Market Analysis for Rising Aging Population, Type, Distribution Channel, End-User, Growth Factors and Competitive Landscape till 2025
November 21, 2019 12:38 ET
|
Data Bridge Market Research
NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Data Bridge Market Research released a new market study on “Advanced Wound Care Market Analysis For Rising Aging Population, Type, Distribution Channel,...
RenovaCare Appoints Alan L. Rubino as President and CEO
November 18, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Nov. 18, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...